Anticoagulation with Bivalirudin Versus Unfractionated Heparin in Transcatheter Aortic Valve Replacement: A Review of the Evidence

Jan 15, 2016   |  Rahul Sharma, MD, FACC

Expert Analysis

Transcatheter aortic valve replacement (TAVR) has established itself as a game-changing treatment strategy for patients with severe aortic stenosis (AS), and high or prohibitive surgical risk. The balloon-expandable SAPIEN heart-valve system...

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Cardiovascular Care Team, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Valvular Heart Disease, Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Aortic Surgery, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Cardiac Surgery and VHD, Interventions and ACS, Interventions and Structural Heart Disease, Interventions and Vascular Medicine, Mitral Regurgitation

Keywords: Acute Coronary Syndrome, Acute Kidney Injury, Anticoagulants, Antithrombins, Aortic Valve, Aortic Valve Stenosis, Atrial Fibrillation, Catheterization, Clinical Trials Data Monitoring Committees, Control Groups, Coronary Vessels, Femoral Artery, Follow-Up Studies, Glomerular Filtration Rate, Glomerular Filtration Rate, Half-Life, Heparin, Hirudins, Ischemic Attack, Transient, Mitral Valve Insufficiency, Myocardial Infarction, Peptide Fragments, Percutaneous Coronary Intervention, Prostheses and Implants, Protamines, Randomized Controlled Trials as Topic, Registries, Renal Dialysis, Research Personnel, Research Personnel, Retrospective Studies, Standard of Care, Stents, Thrombocytopenia, Thrombosis, Transcatheter Aortic Valve Replacement, Vascular System Injuries, Ventricular Dysfunction, Left, Warfarin